Our results show that the frequency of peripheral blood NKG2D+ NK cells was significantly lower in NAFLD patients compared to healthy controls (94,72% (SD = 3,529) vs. 97,04% (SD = 2,375), p = 0,0062) (Fig 2A). This evidence concerns the gene KLRK1 and metabolic dysfunction-associated steatotic liver disease.